2021 Á¦8ȸ ´ëÇѺñ´¢ÀÇÇаúÀÇ»çȸ-´ëÇѳ²¼º°úÇÐȸ On-Line °øµ¿ ½ÉÆ÷Áö¾ö : 2021-07-04±³À°ÀÏÀÚ : 2021-07-04
±³À°Àå¼Ò : ¿Â¶óÀÎ (½Ç½Ã°£ È»ó°ÀÇ ¹æ½Ä)
±³À°ÁÖÁ¦ :
2021 Á¦8ȸ ´ëÇѺñ´¢ÀÇÇаúÀÇ»çȸ-´ëÇѳ²¼º°úÇÐȸ On-Line °øµ¿ ½ÉÆ÷Áö¾öÁÖÃÖ±â°ü : ´ëÇÑ°³¿øÀÇÇùÀÇȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѺñ´¢ÀÇÇаúÀÇ»çȸ
´ã´çÀÚ : ±è¹ÎÈñ
¿¬¶ôó : 02-2038-7988
À̸ÞÀÏ :
gaonpco@gaonpco.com ±³À°Á¾·ù : ºñ´¢ÀÇÇаú
Âü¼®¿¹»óÀοø : 300¸í
Èñ¸ÁÆòÁ¡ : 6Á¡ (ÀÏ¹Ý 5Á¡ / Çʼö 1Á¡)
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 6 ½Ã°£ 55ºÐ
¼¼ºÎ¼ö°·á : 500,000¿ø
ºñ°í ȸ¿ø: 3¸¸¿ø / ºñȸ¿ø: 50¸¸¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 07-04 09:00~09:20 1. Pathophysiology and natural history of Peyronie ¹Ú¹Î±¸(ÀÎÁ¦ÀÇ´ë)
±³À°½Ã°£ 07-04 09:20~09:40 2. How do doctors diagnosis Peyronie ½ÅÈ«¼®(´ë±¸°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 07-04 09:40~10:00 3. Nonsurgical treatment of Peyronie ·ùÁö°£(ÀÎÇÏÀÇ´ë)
±³À°½Ã°£ 07-04 10:00~10:05 Q&A ()
±³À°½Ã°£ 07-04 10:05~10:30 1. Çظéü ÀÚ°¡ÁÖ»ç¿ä¹ýÀÇ ±âº», µÇµ¹¾Æº¸±â ¹ÚÇöÁØ(ºÎ»êÀÇ´ë)
±³À°½Ã°£ 07-04 10:30~10:55 2. Çظéü³» ÀÚ°¡ÁÖ»ç¹ý ½ÇÁ¦ Á¤È£ÁØ(°¨µ¿ºñ´¢ÀÇÇаú)
±³À°½Ã°£ 07-04 10:55~11:00 Q&A ()
ÈÞ½Ä 07-04 11:00~11:10 ÈÞ½Ä ()
±³À°½Ã°£ 07-04 11:10~11:40 1. 3-piece PPI »ç°ÇÀÇ À籸¼º ¹× Àç¹ß¹æÁö¸¦ À§ÇØ ÁÖÀÇÇÒ Á¡ È«¿µ±Õ º¯È£»ç(¹ý·ü»ç¹«¼Ò Èú¸µ)
±³À°½Ã°£ 07-04 11:40~12:10 2. Trimix ¿ø³» Á¶Á¦ - ¹ý·üÀû ¹®Á¦´Â ¾ø´ÂÁö ? ÀÌÁ¤¼± º¯È£»ç(¹ý·ü»ç¹«¼Ò °Ç¿ì)
±³À°½Ã°£ 07-04 12:10~13:00 Á¡½É½Ã°£ ()
±³À°½Ã°£ 07-04 13:00~13:20 1. ¿ì¸® ¾ÆÀÌ Àß Å©°í ÀÖ³ª¿ä - ¼Ò¾Æ û¼Ò³â±âÀÇ ¿Ö¼ÒÀ½°æ°ú Àú¼º¼±Áõ¿¡ ´ëÇÑ Ä«¿î¼¿¸µ Á¤Àç¹Î(ºÎ»êÀÇ´ë)
±³À°½Ã°£ 07-04 13:20~13:40 2. Æ÷°æ¼ö¼ú°ú ¼º±â´É¿¡ ´ëÇÑ Ä«¿î¼¿¸µ - ºñÀü¹®°¡ÀÇ Æ÷°æ¼ö¼ú ÀÎ½Ä ¿Ö°î¿¡ ´ëÇÑ ¿ì¸®ÀÇ ´ëÀÀ ÀÌ¿ø±â(ÇѸ²ÀÇ´ë)
±³À°½Ã°£ 07-04 13:40~14:00 3. Á¤°ü¼ö¼ú Á¤¸» ¾ÈÀüÇÏ°í ±¦ÂúÀ»±î¿ä? - Vasectomy and Prostate Cancer Risk counseling ±è¼ºÇÑ(±¹¸³¾Ï¼¾ÅÍ)
±³À°½Ã°£ 07-04 14:00~14:10 Pannel Discussion µÎÁø°æ(¾îºñ´¢ÀÇÇаú)
±³À°½Ã°£ 07-04 14:10~14:30 1. Definition, cause, & risk À̵¿¼·(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 07-04 14:30~14:50 2. Combination therapy: ¾à¹° ¹× ºñ¾à¹°¿ä¹ý Á¤Çöö(ÇѸ²ÀÇ´ë)
±³À°½Ã°£ 07-04 14:50~15:10 3. Role of combined testosterone therapy ÀÌÁØÈ£(À»ÁöÀÇ´ë)
±³À°½Ã°£ 07-04 15:10~15:30 4. Emerging treatment strategies ¾È¼øÅÂ(°í·ÁÀÇ´ë)
±³À°½Ã°£ 07-04 15:30~15:35 Q&A ()
ÈÞ½Ä 07-04 15:35~15:45 ÈÞ½Ä ()
±³À°½Ã°£ 07-04 15:45~16:15 Benefits of Mirabegron Therapy in OAB patients (Practical experience & Bigdata analysis) ¿©Á¤±Õ(ÀÎÁ¦ÀÇ´ë)